Form 4 for EW Edwards Lifesciences
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-03 · accession 0001225208-24-005704 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-06 | 2024-05-03+ | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $85.16 | -572 | 16.9K | -3% | -$48.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-03 | F | D | 281 | $85.06 | 17,206.74 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-04 | F | D | 291 | $85.25 | 16,915.74 | D | — | — |